Suppr超能文献

4G/5G 多态性和载脂蛋白 E 基因多态性与冠状动脉粥样硬化性疾病的关系。

4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries.

机构信息

Deutsches Herzzentrum München, 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

出版信息

Thromb Haemost. 2010 Jun;103(6):1170-80. doi: 10.1160/TH09-10-0702. Epub 2010 Mar 29.

Abstract

We assessed the association between common variation at the SERPINE1 (PAI1) locus and myocardial infarction (MI). Haplotype-tagging polymorphisms, including the 4G/5G deletion/insertion polymorphism and seven single nucleotide polymorphisms, were analysed in a German sample containing 3,657 cases with MI and 1,211 controls. The association between the 4G/5G polymorphism and MI was examined in a meta-analysis of data extracted from 32 studies (13,267 cases/14,716 controls). In addition, the relation between the 4G/5G polymorphism and coronary diseases, comprising MI, coronary artery disease, coronary heart disease, or the acute coronary syndrome, was assessed in a combined analysis enclosing 43 studies (17,278 cases/18,039 controls). None of the tagging polymorphisms was associated with MI in the present sample (p <or= 0.34). The adjusted odds ratio (OR) for 4G allele carriers was 1.02 (95% confidence interval [CI] 0.87-1.19) compared to the 5G5G genotype. None of 13 common (frequency >1.0%) 8-marker haplotypes was related to the risk of MI. In a meta-analysis specifically addressing the association with MI, no elevated risk was found in the carriers of the 4G allele (OR 1.07, 95% CI 0.99-1.16; p = 0.11). A more general combined analysis of coronary diseases showed a marginally increased risk in 4G allele carriers (OR 1.08, 95% CI 1.00-1.16; p = 0.044). In essence, tagging polymorphisms, including the 4G/5G polymorphism, and common haplotypes of the SERPINE1 gene region were not associated with MI in a German sample, and no compelling evidence was obtained for a relationship of the 4G/5G polymorphism to MI and coronary atherosclerosis in a meta-analysis.

摘要

我们评估了丝氨酸蛋白酶抑制剂 1(PAI1)基因座的常见变异与心肌梗死(MI)之间的关联。在一个包含 3657 例 MI 患者和 1211 例对照的德国样本中,分析了包括 4G/5G 缺失/插入多态性和七个单核苷酸多态性的单体型标签多态性。在对 32 项研究(13267 例病例/14716 例对照)提取的数据进行的荟萃分析中,检查了 4G/5G 多态性与 MI 的关系。此外,在一项包括 43 项研究(17278 例病例/18039 例对照)的综合分析中,评估了 4G/5G 多态性与包含 MI、冠状动脉疾病、冠心病或急性冠状动脉综合征的冠状动脉疾病之间的关系。在本样本中,没有一个标签多态性与 MI 相关(p<0.05)。与 5G5G 基因型相比,4G 等位基因携带者的调整比值比(OR)为 1.02(95%置信区间[CI]0.87-1.19)。没有一个常见(频率>1.0%)的 8 标记单体型与 MI 风险相关。在专门针对与 MI 关联的荟萃分析中,4G 等位基因携带者没有发现风险增加(OR 1.07,95%CI 0.99-1.16;p=0.11)。对冠状动脉疾病的更一般综合分析显示,4G 等位基因携带者的风险略有增加(OR 1.08,95%CI 1.00-1.16;p=0.044)。总之,在德国样本中,包括 4G/5G 多态性在内的单体型标签多态性以及丝氨酸蛋白酶抑制剂 1 基因区域的常见单体型与 MI 无关,并且在荟萃分析中也没有获得 4G/5G 多态性与 MI 和冠状动脉粥样硬化之间关系的令人信服的证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验